Bookmark
Forward
More than 2% circulating plasma cells as a prognostic biomarker in a large cohort of patients with newly-diagnosed multiple myeloma.
Mengru Tian, Xinyue Liang, Weiling Xu, Xingcheng Yi, Tingting Yue, Yingjie Zhang, Shanshan Yu, Yurong Yan, Zhongli Hu, Nan Zhang, Jingxuan Wang, Rui Hu, Xiaoxiao Sun, Yuanyuan Nie, Yun Dai, Fengyan Jin
Annals of hematology 2023 OctNo abstract available.
Citation
Mengru Tian, Xinyue Liang, Weiling Xu, Xingcheng Yi, Tingting Yue, Yingjie Zhang, Shanshan Yu, Yurong Yan, Zhongli Hu, Nan Zhang, Jingxuan Wang, Rui Hu, Xiaoxiao Sun, Yuanyuan Nie, Yun Dai, Fengyan Jin. More than 2% circulating plasma cells as a prognostic biomarker in a large cohort of patients with newly-diagnosed multiple myeloma. Annals of hematology. 2023 Oct;102(10):2943-2945
Mesh Tags
Substances
PMID: 37434095
View Full Text
